Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 29, 2026ESMO rare cancers.Open Access

Cellularity in myxoid liposarcoma: association with tumor immune microenvironment and patient outcomes

View Full Paper
Ask AI
Bookmark
Share

Authors

MBM. BarisellaFondazione IRCCS Istituto Nazionale dei TumoriVVViviana VallacchiFondazione IRCCS Istituto Nazionale dei TumoriABAlessia BertolottiFondazione IRCCS Istituto Nazionale dei Tumori

Discussion

Loading...

Member takes

Implication

Observational study demonstrates that high cellularity correlates with relapse and elevated immune infiltration in myxoid liposarcoma, highlighting novel risk-stratification markers.

Key Points

  • To describe the morphological cellularity patterns of untreated primary myxoid liposarcoma and investigate their relationship with tumor immune microenvironment infiltration and disease recurrence.
  • Evaluated primary, untreated myxoid liposarcoma specimens from 35 patients (N=35).
  • Scored tumor histology across classic, transitional (densities A, B, and C), and round cell components.
  • Profiled the tumor immune microenvironment at regions of highest immune infiltration, highest and lowest cellularity, and the tumor border.
  • All 35 tumors showed multiple morphological components, with classic present in 91.4% (32/35), transitional in 97.1% (34/35), type C density in 45.7% (16/35), and round cell in 31.4% (11/35).
  • Patients who experienced disease relapse (n=6) were significantly more likely to harbor transitional component type C density, round cell component, or both (P=0.014).
  • Immune cell enrichment peaked at tumor borders and high-infiltrate zones, with elevated T cells and tumor-associated macrophages observed in type C transitional and round cell components.

Cite This Study

Barisella et al. (2026) studied this question.

synapsesocial.com/papers/6a9299088e5d7d1fc0c10b6bhttps://doi.org/10.1016/j.esmorc.2026.100518
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma2011 · 149 citations
  2. 2Short, Full-Dose Adjuvant Chemotherapy in High-Risk Adult Soft Tissue Sarcomas: A Randomized Clinical Trial From the Italian Sarcoma Group and the Spanish Sarcoma Group2012 · 191 citations
  3. 3Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways2015 · 91 citations